Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

GENETIC SIGNATURES LIMITED

INVESTOR PRESENTATION - GENETIC SIGNATURES LIMITED

ASX:GSS

GENETIC SIGNATURES LIMITED

Health Care

Genetic Signatures Limited (GSS) is a molecular diagnostic (MDx) company operating in the global in vitro diagnostics (IVD) market. The Company designs and manufactures proprietary molecular diagnostic test solutions for rapid and specific identification of infectious diseases.

Read more

Market Cap

281.39m

Price at Close

$1.97

4w avg. Volume

135.31k

4w avg. Turnover

$257.46k

Announcements
announcementt+2 movementdate
  • Change in substantial holding

    Shareholder Details

  • -

    27 Oct 2020

-

27 Oct 2020
  • Ceasing to be a substantial holder

    Shareholder Details

  • -

    26 Oct 2020

-

26 Oct 2020
  • Quarterly update and Appendix 4C

    Commitments test entity quarterly reports · Market sensitive

  • -2.91%

    22 Oct 2020

-2.91%

22 Oct 2020
  • Appendix 2A

    Issued Capital

  • +4.76%

    21 Oct 2020

+4.76%

21 Oct 2020
  • Appendix 4G & corporate governance statement

    Periodic Reports

  • -1.03%

    16 Oct 2020

-1.03%

16 Oct 2020
  • Annual Report to shareholders

    Periodic Reports

  • -1.03%

    16 Oct 2020

-1.03%

16 Oct 2020
  • Notice of Annual General Meeting/Proxy Form

    Notice Of Meeting

  • -1.03%

    16 Oct 2020

-1.03%

16 Oct 2020
  • First quarter sales update

    Periodic Reports · Market sensitive

  • +11.76%

    01 Oct 2020

+11.76%

01 Oct 2020
  • Appendix 2A

    Issued Capital

  • -2.50%

    10 Sep 2020

-2.50%

10 Sep 2020
  • CEO presenting at ShareCafe webinar

    Company Administration

  • -0.87%

    27 Aug 2020

-0.87%

27 Aug 2020
Market Data

Current Price

$1.97

52WK HIGH

$2.94

52WK LOW

$0.9

1YR RETURN

+91.26%

1YR RETURN VS. SECTOR

-191.31%

90 DAY RETURN

-25.10%

ASX RANK

481

/2,015

SECTOR RANK

1

/9

SHARES OUTSTANDING

142.84m
ASX:GSS

GENETIC SIGNATURES LIMITED

Health Care

Genetic Signatures Limited (GSS) is a molecular diagnostic (MDx) company operating in the global in vitro diagnostics (IVD) market. The Company designs and manufactures proprietary molecular diagnostic test solutions for rapid and specific identification of infectious diseases.

Read more

Market Cap

281.39m

Price at Close

$1.97

4w avg. Volume

135.31k

4w avg. Turnover

$257.46k

ASX:GSS is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.